Cargando…

Two-year Outcomes of XEN Implantation with Minimal Bleb Needling

AIM: Our study aims to report the 2 years outcomes of the XEN implant in a single unit, single surgeon setting with minimal bleb needling. METHODS: A retrospective cohort study was conducted. Inclusion criteria were patients who underwent implantation with a XEN device between May 2016 and December...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Zaria C, Moshin, Nadeem, Hakim, Mohamad T, Shankar, Vikas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452704/
https://www.ncbi.nlm.nih.gov/pubmed/36128083
http://dx.doi.org/10.5005/jp-journals-10078-1363
_version_ 1784784969092038656
author Ali, Zaria C
Moshin, Nadeem
Hakim, Mohamad T
Shankar, Vikas
author_facet Ali, Zaria C
Moshin, Nadeem
Hakim, Mohamad T
Shankar, Vikas
author_sort Ali, Zaria C
collection PubMed
description AIM: Our study aims to report the 2 years outcomes of the XEN implant in a single unit, single surgeon setting with minimal bleb needling. METHODS: A retrospective cohort study was conducted. Inclusion criteria were patients who underwent implantation with a XEN device between May 2016 and December 2017. This included patients who underwent both combined phacoemulsification and intraocular lens implantation alongside XEN implantation and those who underwent XEN implantation alone. Data gathered included basic demographic data, best-corrected visual acuity (LogMAR), intraocular pressure (IOP) in mm Hg, mean deviation from their visual field test, and the number of IOP-lowering medications they were on. This information was recorded for their preoperative visit, and then at 6, 12, 18 and 24 months postoperatively. The primary outcome assessed was a complete success when the patient was without glaucoma medications and had an IOP of 18 mm Hg or less, but more importantly, this also had to equate to a 20% reduction in IOP compared to baseline. Qualified success was defined as the same change in IOP but with medications. Surgical failure is defined as those who required additional glaucoma surgery or those who did not obtain an IOP of 18 mm Hg alongside a 20% reduction in IOP compared to baseline. RESULTS: At 24 months follow-up 82.5% of patients were surgical successes. Complete surgical success was achieved in 27% of patients. Qualified surgical success was achieved in 55.6% of patients. Subgroup analysis of those undergoing XEN implantation on its own and those combined with phacoemulsification + IOL were similar. The rate of bleb needling was low at 4.5%. Complication rates were acceptable at 9.5%. CONCLUSION: It is possible to get good IOP control with minimal postoperative bleb needling in patients who have undergone XEN implantation. Similar success rates are found in those undergoing combined procedures. CLINICAL SIGNIFICANCE: Bleb needling carries its own risks. Minimizing the number of bleb needling allows procedures to be reserved at a later date. Furthermore, our study shows that success rates are not affected by doing a combined procedure with phacoemulsification. HOW TO CITE THIS ARTICLE: Ali ZC, Moshin N, Hakim MT, et al. Two-year Outcomes of XEN Implantation with Minimal Bleb Needling. J Curr Glaucoma Pract 2022;16(2):79-83.
format Online
Article
Text
id pubmed-9452704
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Jaypee Brothers Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-94527042022-09-19 Two-year Outcomes of XEN Implantation with Minimal Bleb Needling Ali, Zaria C Moshin, Nadeem Hakim, Mohamad T Shankar, Vikas J Curr Glaucoma Pract Original Research AIM: Our study aims to report the 2 years outcomes of the XEN implant in a single unit, single surgeon setting with minimal bleb needling. METHODS: A retrospective cohort study was conducted. Inclusion criteria were patients who underwent implantation with a XEN device between May 2016 and December 2017. This included patients who underwent both combined phacoemulsification and intraocular lens implantation alongside XEN implantation and those who underwent XEN implantation alone. Data gathered included basic demographic data, best-corrected visual acuity (LogMAR), intraocular pressure (IOP) in mm Hg, mean deviation from their visual field test, and the number of IOP-lowering medications they were on. This information was recorded for their preoperative visit, and then at 6, 12, 18 and 24 months postoperatively. The primary outcome assessed was a complete success when the patient was without glaucoma medications and had an IOP of 18 mm Hg or less, but more importantly, this also had to equate to a 20% reduction in IOP compared to baseline. Qualified success was defined as the same change in IOP but with medications. Surgical failure is defined as those who required additional glaucoma surgery or those who did not obtain an IOP of 18 mm Hg alongside a 20% reduction in IOP compared to baseline. RESULTS: At 24 months follow-up 82.5% of patients were surgical successes. Complete surgical success was achieved in 27% of patients. Qualified surgical success was achieved in 55.6% of patients. Subgroup analysis of those undergoing XEN implantation on its own and those combined with phacoemulsification + IOL were similar. The rate of bleb needling was low at 4.5%. Complication rates were acceptable at 9.5%. CONCLUSION: It is possible to get good IOP control with minimal postoperative bleb needling in patients who have undergone XEN implantation. Similar success rates are found in those undergoing combined procedures. CLINICAL SIGNIFICANCE: Bleb needling carries its own risks. Minimizing the number of bleb needling allows procedures to be reserved at a later date. Furthermore, our study shows that success rates are not affected by doing a combined procedure with phacoemulsification. HOW TO CITE THIS ARTICLE: Ali ZC, Moshin N, Hakim MT, et al. Two-year Outcomes of XEN Implantation with Minimal Bleb Needling. J Curr Glaucoma Pract 2022;16(2):79-83. Jaypee Brothers Medical Publishers 2022 /pmc/articles/PMC9452704/ /pubmed/36128083 http://dx.doi.org/10.5005/jp-journals-10078-1363 Text en Copyright © 2022; The Author(s). https://creativecommons.org/licenses/by-nc/4.0/© The Author(s). 2022 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Research
Ali, Zaria C
Moshin, Nadeem
Hakim, Mohamad T
Shankar, Vikas
Two-year Outcomes of XEN Implantation with Minimal Bleb Needling
title Two-year Outcomes of XEN Implantation with Minimal Bleb Needling
title_full Two-year Outcomes of XEN Implantation with Minimal Bleb Needling
title_fullStr Two-year Outcomes of XEN Implantation with Minimal Bleb Needling
title_full_unstemmed Two-year Outcomes of XEN Implantation with Minimal Bleb Needling
title_short Two-year Outcomes of XEN Implantation with Minimal Bleb Needling
title_sort two-year outcomes of xen implantation with minimal bleb needling
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452704/
https://www.ncbi.nlm.nih.gov/pubmed/36128083
http://dx.doi.org/10.5005/jp-journals-10078-1363
work_keys_str_mv AT alizariac twoyearoutcomesofxenimplantationwithminimalblebneedling
AT moshinnadeem twoyearoutcomesofxenimplantationwithminimalblebneedling
AT hakimmohamadt twoyearoutcomesofxenimplantationwithminimalblebneedling
AT shankarvikas twoyearoutcomesofxenimplantationwithminimalblebneedling